Add time:07/29/2019         Source:sciencedirect.com

ObjectivesStatistical methods to adjust for treatment switching are commonly applied to randomized controlled trials (RCTs) in oncology. Nevertheless, RCTs with extension studies incorporating nonrandomized dropout require consideration of alternative adjustment methods. The current study used a recognized method and a novel method to adjust for treatment switching in relapsing–remitting multiple sclerosis (MS).

We also recommend Trading Suppliers and Manufacturers of CLARITY (cas 104040-79-1). Pls Click Website Link as below: cas 104040-79-1 suppliers